Federal Register #2026-12142

DEA Notice: Application to Import Methamphetamine for Manufacturing by Aphena Pharma Solutions MD, LLC

This notice concerns the Drug Enforcement Administration (DEA), under the Department of Justice, and Aphena Pharma Solutions MD, LLC's application to import methamphetamine for manufacturing purposes. - Government Buyer: - Department of Justice (DOJ) - Drug Enforcement Administration (DEA) - OEM/Vendor: - Aphena Pharma Solutions MD, LLC (applicant and manufacturer) - Product/Service Requested: - Methamphetamine (Drug Code 1105, Schedule II) - For internal use in manufacturing an FDA-approved exempt over-the-counter drug product - No finished dosage forms for commercial sale are authorized - No specific quantities or part numbers provided - Unique/Notable Requirements: - Importation is strictly for internal manufacturing use, not for commercial sale - Activities must comply with 21 U.S.C. 952(a)(2) - Registration does not permit other activities for this drug code - Public comments and hearing requests are allowed electronically - Docket No. DEA-1728 is associated with this application

Description

Aphena Pharma Solutions MD, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). The application involves the import of methamphetamine (Schedule II) for internal use in manufacturing an FDA-approved exempt over-the-counter drug product. Comments or objections to the application can be submitted electronically by July 17, 2026. Requests for a hearing must also be filed by this date. The application is associated with Docket No. DEA-1728 and was published in the Federal Register on June 17, 2026.

View original listing